Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
antidepressant |
| gptkbp:activeIngredient |
mirtazapine
|
| gptkbp:approvedBy |
1996
|
| gptkbp:ATCCode |
N06AX11
|
| gptkbp:brand |
gptkb:Avanza
gptkb:Remeron Mirtaz |
| gptkbp:chemicalClass |
antidepressant
|
| gptkbp:form |
gptkb:tablet
orodispersible tablet |
| https://www.w3.org/2000/01/rdf-schema#label |
Zispin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedAs |
gptkb:Organon
|
| gptkbp:mechanismOfAction |
noradrenergic and specific serotonergic antidepressant (NaSSA)
|
| gptkbp:pregnancyCategory |
gptkb:C_(Australia)
C (US) |
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
weight gain
drowsiness dry mouth increased appetite |
| gptkbp:usedFor |
gptkb:major_depressive_disorder
|
| gptkbp:bfsParent |
gptkb:Mirtazapine
|
| gptkbp:bfsLayer |
7
|